Your Article Summary
See Latest ArticlesWatson Pharmaceuticals Appoints Christopher W. Bodine to Board of Directors
Watson Pharmaceuticals, 06/30/09
Watson Pharmaceuticals, Inc. , a leader in generic and specialty branded pharmaceuticals, today announced the appointment of Christopher W. Bodine to its Board of Directors, effective immediately. The addition of Mr. Bodine expands Watson's Board to ten members, of whom nine are independent. Mr. Bodine's career spans 36 years with two of the nation's leading retail and healthcare companies and brings to Watson a significant chain drug industry background.
Today in Execs on the Move...keeping you current
Receive free subspecialty "5-minute updates" via email
Genmab to present at 21st annual piper jaffray health care conference
Genmab, 12/02/09
Mylans President of Europe, Middle East and Africa Elected President of European Generic Medicines Association
Mylan, 11/19/09
Storrer to Lead MEDecision
HealthDataManagement, 11/18/09